BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Grunenthal GmbH 

Pascalstraße 6

Aachen    52076  Germany
Phone: 0241-569-1111 Fax: 0241-569-1112


SEARCH JOBS


Industry
Pharmaceutical






 Company News
AcelRx Pharmaceuticals (ACRX), Grunenthal GmbH Strike Deal Worth $250 Million For Pain Treatment Drug 12/16/2013 9:42:18 AM    More...
Grunenthal GmbH Expands Use of BioClinica, Inc.'s Next Generation Trident IWR/IVR for Global Trial 6/21/2013 9:25:23 AM    More...
EFIC-Grünenthal-Grant Awards Seven Innovative Research Projects 6/6/2013 9:46:45 AM    More...
Grunenthal GmbH Presents a New Website for the Topical Treatment of Postherpetic Neuralgia (PHN) 5/22/2013 9:55:09 AM    More...
Grunenthal GmbH Highlights Significant R&D Advances in Pain, Inflammation as well as INTAC® Tamper-Resistant Technology at World's Largest Biotechnology Conference 4/19/2013 7:40:46 AM    More...
Grunenthal GmbH to Present Data for Its Innovative Formulation Technology INTAC® at PAINWeek 2012 9/6/2012 10:15:58 AM    More...
Grunenthal GmbH to Present Its Tamper Resistant Formulation Technology INTAC® at the Meeting & Exposition of the Controlled Release Society 7/13/2012 10:27:11 AM    More...
Horizon Pharma, Inc. Enters into Exclusive Agreement with Grunenthal GmbH for Commercialization of DUEXIS® in Latin America 6/19/2012 11:37:11 AM    More...
Grunenthal GmbH to Present at 2012 Biotechnology Industry Organization (BIO) International Convention on June 20, 2012, in Boston MA, US 6/15/2012 10:26:09 AM    More...
Grunenthal GmbH Presents Strong Pipeline at World's Largest Biotechnology Conference 6/14/2012 11:17:45 AM    More...
1234

//-->